FIC Capital’s Zimmer Biomet ZBH Stock Holding History

FIC Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,741	Closed	-$217K	–	120
2017 Q2	$217K	Sell	1,741 -51	-3%	-$6.05K	0.09%	110
2017 Q1	$212K	Buy	+1,792	New	+$203K	0.09%	109
2016 Q4	–	Sell	-1,792	Closed	-$226K	–	120
2016 Q3	$226K	Hold	1,792	–	–	0.1%	108
2016 Q2	$209K	Buy	+1,792	New	+$203K	0.1%	113
2015 Q2	–	Sell	-1,792	Closed	-$204K	–	126
2015 Q1	$204K	Buy	+1,792	New	+$204K	0.08%	124

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FIC Capital's ZBH Position: Q3 2017 in Review

FIC Capital sold out of Zimmer Biomet (ZBH) in Q3 2017, closing a stake of 1,741 shares — an estimated $217K sold.

FIC Capital first reported a position in ZBH in Q1 2015 and held it in 5 quarters. The position peaked at $226K in Q3 2016. 818 funds tracked by Wall St. Rank hold ZBH as of Q3 2017.

FIC Capital reported no remaining Zimmer Biomet position as of Q3 2017 after selling out during the quarter.
FIC Capital sold 1,741 Zimmer Biomet shares in Q3 2017, an estimated $217K.
FIC Capital first reported a position in Zimmer Biomet in Q1 2015 and held it in 5 quarters.
FIC Capital's Zimmer Biomet position peaked at $226K in Q3 2016.
818 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.